- Ferroptosis and pyroptosis signatures in critical COVID-19 patients(2023)
Auteurs: Cédric Peleman, Samya Van Coillie, Symen Ligthart, Jan De Waele, Pieter Depuydt, Dominique Benoit, Hannah Schaubroeck, Sven M. Francque, Karolien Dams, Rita Jacobs, et al.
Pagina's: 2066 - 2077
- Targeting ferroptosis protects against experimental (multi)organ dysfunction and death(2022)
Auteurs: Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts, Geert Dams, et al.
- Therapeutic targeting of ferroptosis in experimental models of acute organ injury(2021)
Auteurs: Samya Van Coillie
- Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor(2021)
Auteurs: Tom Delanghe, Jon Huyghe, Seungheon Lee, Dario Priem, Samya Van Coillie, Barbara Gilbert, Peter Vandenabeele, Alexei Degterev, Gregory D. Cuny, Yves Dondelinger, et al.
- Molecular and cellularf unctions of CTLA-4(2020)
Auteurs: Samya Van Coillie, Bartosz Wiernicki, Jie Xu
Pagina's: 7 - 32
- Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19) : autopsy reveals a ferroptosis signature(2020)
Auteurs: Werner Jacobs, Martin Lammens, Annelies Kerckhofs, Evy Voets, Emily Van San, Samya Van Coillie, Cedric Peleman, Matthias Mergeay, Sabriya Sirimsi, Veerle Matheeussen, et al.
- Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2(2018)
Auteurs: Alessandro Annibaldi, Sidonie Wicky John, Tom Vanden Berghe, Kirby N Swatek, Jianbin Ruan, Gianmaria Liccardi, Katiuscia Bianchi, Paul R Elliott, Samya Van Coillie, John Bertin, et al.
Pagina's: 566 - 580
- Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy(2018)
Auteurs: Lars Devisscher, Samya Van Coillie, Sam Hofmans, Dries Van Rompaey, Kenneth Goossens, Eline Meul, Louis Maes, Hans De Winter, Pieter Van Der Veken, Peter Vandenabeele, et al.
Pagina's: 10126 - 10140